Home
Mohn Cancer Research Laboratory

News archive for Mohn Cancer Research Laboratory

Research on PARP inhibitors carried out at Mohn Cancer Research Laboratory and KG Jebsen's center for genome-directed cancer therapy receives attention in the international press after publication in the Annals of Oncology.
Bergens Tidende shares the story of Elisabeth Thomassen, who receives support from the am-car community to raise money to try treatment in the USA.
Bergens Tidende shares the story of Aud and Kristel on 5 November; two ladies who have both been treated for breast cancer.
In December 2018, professor Per Eystein lønning and senior researcher Stian Knappskog each received a new research grant of 10 mill NOK from the Norwegian Research Council under the FRIMEDBIO program. Since only 5-10% of all applications to this program are funded, we are very happy that two groups within our research environment received such grants.
In December 2018, professor Per Eystein lønning and senior researcher Stian Knappskog each received a new research grant of 10 mill NOK from the Norwegian Research Council under the FRIMEDBIO program. Since only 5-10% of all applications to this program are funded, we are very happy that two groups within our research environment received such grants.